Avenue therapeutics, inc. reports earnings results for the third quarter ended september 30, 2019

Avenue therapeutics, inc. announced earnings results for the third quarter ended september 30, 2019. for the third quarter, the company announced operating loss was usd 2.323 million compared to usd 2.608 million a year ago. net loss was usd 2.242 million compared to usd 2.595 million a year ago. basic loss per share was usd 0.14 compared to usd 0.25 a year ago. for the nine months, operating loss was usd 20.791 million compared to usd 17.714 million a year ago. net loss was usd 20.493 million compared to usd 17.629 million a year ago. basic loss per share was usd 1.32 compared to usd 1.73 a year ago.
ATXI Ratings Summary
ATXI Quant Ranking